Endoscopy Devices Market: Single-Use Endoscope Adoption, Robotic Endoscopy, and 4K Ultra-HD Visualisation to Drive Sustained Market Growth Through 2035

The global Endoscopy Devices market was valued at USD 62.1 billion in 2025 and is projected to reach USD 90.71 billion by 2035, advancing at a CAGR of 4.3%. The market encompasses the full continuum of endoscopic technology: reusable rigid and flexible endoscopes across gastroscopes, colonoscopes, bronchoscopes, duodenoscopes, ureteroscopes, cystoscopes, hysteroscopes, laparoscopes, arthroscopes, and neuroendoscopes; disposable single-use endoscopes across all major endoscope categories; capsule endoscopes; robot-assisted endoscopes; endoscopy visualisation systems including standard-definition, high-definition, 3D, 4K ultra-HD, and fluorescence imaging platforms; camera heads, video processors, medical monitors, light sources, insufflators, and suction pumps; endoscopic operative devices including energy instruments, access trocars, hand instruments, tissue management tools, haemostasis devices, and closure systems; and endoscopy accessories and consumables including biopsy needles, guidewires, balloons, dilators, and reprocessing accessories.

Two macro trends are structurally reshaping the endoscopy devices market: the rapid growth of single-use disposable endoscopes driven by healthcare system infection control imperatives following high-profile carbapenem-resistant organism outbreaks linked to reusable duodenoscope reprocessing failures, and the advancement of 4K ultra-HD and fluorescence near-infrared imaging platforms that provide tissue visualisation detail and real-time perfusion assessment capabilities that were not available in standard endoscopy suites until recently. These forces are simultaneously growing the addressable market and elevating the per-procedure device revenue through premium system and consumable adoption.

Executive Snapshot

What infection control events are driving single-use disposable endoscope adoption across gastroenterology and bronchoscopy?
Healthcare-associated infections transmitted through inadequately reprocessed flexible endoscopes — most prominently multidrug-resistant organism (MDRO) outbreaks linked to duodenoscope elevator mechanisms that are difficult to clean and disinfect with standard automated reprocessing — generated regulatory scrutiny and manufacturer redesign mandates that accelerated hospital evaluation of single-use endoscope alternatives. Single-use bronchoscopes initially demonstrated adoption in ICU flexible bronchoscopy settings where cross-contamination risk is high among immunocompromised patients, and single-use ureteroscopes achieved rapid uptake in urological endoscopy given the high reprocessing cost and fragility of fibre-optic ureteroscopes. Duodenoscope single-use adoption is now accelerating across ERCP programmes.

How are 4K ultra-HD visualisation systems improving endoscopic detection and intervention outcomes?
4K ultra-HD endoscopy systems delivering four times the pixel resolution of full-HD 1080p systems provide the enhanced mucosal surface detail, crypt pattern, and vessel architecture visibility that enables reliable characterisation of colonic polyp histology and gastric lesion margins using optical biopsy techniques that avoid biopsy sample acquisition. Published detection studies comparing 4K to HD colonoscopy report improvement in adenoma detection rate, the primary quality metric predictive of post-colonoscopy colorectal cancer risk, at centres where 4K adoption coincided with endoscopist training in optical biopsy characterisation. 4K adoption also enables more precise endoscopic submucosal dissection margin delineation.

What role does near-infrared fluorescence imaging play in laparoscopic and thoracoscopic surgery?
Near-infrared fluorescence imaging systems using indocyanine green dye and near-infrared light sources integrated within laparoscopic and thoracoscopic camera systems enable real-time intraoperative visualisation of tissue perfusion, biliary anatomy during cholecystectomy, lymphatic channels during oncologic lymph node mapping, and ureteral course identification during complex pelvic surgery. These applications directly reduce major surgical complication rates by enabling identification of anatomy that is invisible under white-light laparoscopy. Fluorescence laparoscopy adoption is growing across colorectal surgery, hepatobiliary surgery, and thoracoscopic pulmonary lobectomy programmes.

How is robotic endoscopy advancing beyond laparoscopy into luminal gastroenterology?
Robotic flexible endoscopy systems providing physician-controlled manual manipulation of a robotic catheter steered through gastrointestinal luminal anatomy are beginning commercial deployment in complex ERCP, endoscopic submucosal dissection, and per-oral endoscopic myotomy procedures where bimanual instrument control and scope tip stability improve procedural precision above conventional endoscopy. Robotic colonoscopy systems using a self-propelling mechanism to navigate colon anatomy without endoscopist manual torque are in clinical evaluation for caecal intubation rate improvement and patient comfort.

What is sustaining demand for endoscopic operative device and consumable categories above capital system replacement cycles?
Endoscopic operative device consumables — biopsy forceps, haemostasis clips, injection needles, snares, retrieval baskets, guidewires, and stents — generate recurring per-procedure revenue from the large installed base of flexible endoscope procedures globally. Therapeutic endoscopy procedure volumes including endoscopic mucosal resection, endoscopic submucosal dissection, endoscopic haemostasis, and endoscopic bariatric procedures are growing above diagnostic endoscopy volumes, sustaining higher per-procedure device cost as complex therapeutic procedures utilise more accessory devices per case.

Which endoscopy device segments are growing the fastest?
Single-use disposable endoscopes across bronchoscopy, ureteroscopy, and ERCP, near-infrared fluorescence laparoscopy integration in colorectal and hepatobiliary surgery, robotic flexible endoscopy for complex therapeutic GI procedures, and endoscopic submucosal dissection technique growth in the treatment of early gastrointestinal neoplasia are the fastest-growing endoscopy device segments.

Market Dynamics: Endoscopy Devices Market

  • Single-use disposable endoscope adoption accelerating across duodenoscopy, bronchoscopy, and ureteroscopy following MDRO outbreak-driven reprocessing failure mandates.
    Disposable endoscope adoption growing across ERCP, bronchoscopy, and urology endoscopy from infection control imperatives and reprocessing failure mandates at major healthcare systems.
  • 4K ultra-HD visualisation systems improving adenoma detection rates and enabling optical polyp characterisation above standard HD endoscopy baseline.
    4K endoscopy adoption sustaining capital replacement investment at colonoscopy screening and therapeutic endoscopy programmes targeting measurable quality and detection improvements.
  • Near-infrared fluorescence laparoscopy enabling real-time tissue perfusion and biliary anatomy visualisation, reducing major surgical complication rates in colorectal, hepatobiliary, and urological surgery.
    Fluorescence imaging integration sustaining premium laparoscopy camera and system investment at surgical programmes targeting complication rate reduction through anatomical visualisation improvement.
  • Therapeutic endoscopy procedure volumes growing above diagnostic baseline as ESD, EMR, haemostasis, and endoscopic bariatric procedures utilise higher per-case accessory device revenue.
    Therapeutic endoscopy procedure growth sustaining above-diagnostic-baseline consumable revenue from higher per-case device utilisation in complex therapeutic procedures.
  • Robotic flexible endoscopy advancing in ERCP and per-oral endoscopic myotomy applications requiring bimanual instrument control above conventional endoscope capability.
    Robotic GI endoscopy expanding in complex therapeutic ERCP, POEM, and ESD applications where robotic catheter control improves procedural precision above manual endoscopy technique.
  • Endoscopic bariatric procedure growth including intragastric balloon and endoscopic sleeve gastroplasty sustaining high per-procedure device revenue above standard diagnostic GI endoscopy.
    Endoscopic bariatric procedures sustaining above-diagnostic-endoscopy device revenue per case from the specialised device systems required for bariatric endoscopy interventions.

Market Segmentation: Endoscopy Devices Market

By Procedure
  • Diagnostic Endoscopy
  • Therapeutic Endoscopy
  • Minimally Invasive Surgery (MIS)
  • Endoscopic Resection
  • Endoscopic Hemostasis
  • Endoscopic Bariatric Procedures
  • Other Procedures
By Usability
  • Reusable Devices
  • Disposable (Single-Use) Devices
By End User
  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Outpatient Facilities
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Other End Users
By Product Type
  • Endoscopes
    • Reusable Endoscopes
      • Rigid Endoscopes
        • Laparoscopes
        • Arthroscopes
        • Ureteroscopes
        • Cystoscopes
        • Gynecology Endoscopes
        • Neuroendoscopes
        • Bronchoscopes
        • Hysteroscopes
        • Laryngoscopes
        • Sinuscopes
        • Otoscopes
        • Pharyngoscopes
        • Nasopharyngoscopes
        • Rhinoscopes
        • Gastrointestinal Endoscopes
        • Gastroscopes
          • Enteroscopes
          • Sigmoidoscopes
          • Duodenoscopes
          • Colonoscopes
        • Flexible Endoscopes
          • Gastroscopes
          • Colonoscopes
          • Enteroscopes
          • Sigmoidoscopes
          • Duodenoscopes
          • Bronchoscopes
          • Cystoscopes
          • Ureteroscopes
          • Hysteroscopes
          • Laryngoscopes
          • Rhinoscopes
          • Neuroendoscopes
          • Arthroscopes
          • Laparoscopes
          • Other Flexible Endoscopes
        • Capsule Endoscopes
        • Robot-Assisted Endoscopes
    • Disposable (Single-Use) Endoscopes
      • Bronchoscopes
      • Ureteroscopes
      • Cystoscopes
      • Gastroscopes
      • Colonoscopes
      • Duodenoscopes
      • Hysteroscopes
      • Arthroscopes
      • Laparoscopes
      • Rhinoscopes
      • Otoscopes
      • Other Disposable Endoscopes
  • Endoscopy Visualization Systems
    • Visualization Platforms
      • Standard Definition (SD) Systems
        • 2D Systems
        • 3D Systems
      • High Definition (HD) Systems
        • 2D Systems
        • 3D Systems
      • 4K Ultra-HD Systems
      • 3D/4K Imaging Systems
      • Fluorescence Imaging Systems (ICG/NIR)
      • AI-Assisted Visualization Systems
    • Visualization Components
      • Camera Heads
      • Video Processors
      • Medical Monitors
      • Light Sources
      • Insufflators
      • Suction Pumps
      • Recording & Documentation Systems
      • Image Management Software
  • Endoscopic Operative Devices
    • Energy Devices
      • Electrosurgical Devices
      • Ultrasonic Energy Devices
      • Radiofrequency Devices
      • Laser Systems
    • Access Devices
      • Trocars
      • Cannulas
      • Access Ports
    • Hand Instruments
      • Forceps
      • Scissors
      • Needle Holders
      • Graspers
      • Dissectors
    • Suction & Irrigation Systems
    • Tissue Management Devices
      • Snares
      • Biopsy Forceps
      • Retrieval Baskets
      • Hemostasis Clips
      • Injection Needles
    • Wound Retractors
    • Closure Devices
      • Endoscopic Suturing Systems
      • Stapling Devices
  • Endoscopy Accessories & Consumables
    • Biopsy Needles
    • Cytology Brushes
    • Guidewires
    • Balloons
    • Dilators
    • Cleaning & Reprocessing Accessories
    • Sterilization Products
    • Other Consumables
By Application
  • Gastroenterology
  • Pulmonology
  • Urology
  • Gynecology
  • Orthopedics
  • General Surgery
  • ENT (Ear, Nose & Throat)
  • Neurology
  • Oncology
  • Bariatric Surgery
  • Pediatric Endoscopy
  • Other Applications
By Geography
  • North America: United States, Canada, and Mexico
  • Europe:  Germany, U.K., France, Italy, Spain, Russia, Benelux, Nordics, and Rest of Europe
  • Asia Pacific: China, Japan, India, South Korea, Australia, New Zealand, Taiwan, South East Asia, and Rest of Asia Pacific
  • Latin America: Brazil, Argentina, Columbia, Chile, Peru, and Rest of Latin America
  • Middle East: Saudi Arabia, United Arab Emirates, Oman, Qatar, and Rest of Middle East
  • Africa: Nigeria, Egypt, Ethiopia, South Africa, and Rest of Africa

Key Growth Drivers: Endoscopy Devices Market

  1. Single-use endoscope adoption accelerating from MDRO outbreak-driven reprocessing failure mandates across duodenoscopy, bronchoscopy, and ureteroscopy.
    Disposable endoscope adoption growing from infection control imperatives and reprocessing failure mandates, sustaining single-use endoscope market revenue growth above reusable system replacement cycles.
  2. 4K ultra-HD visualisation improving adenoma detection rates and enabling optical polyp characterisation, sustaining premium system adoption at colonoscopy screening programmes.
    4K endoscopy capital replacement investment sustained at screening colonoscopy programmes targeting measurable ADR improvement and optical biopsy capability.
  3. Fluorescence laparoscopy reducing major surgical complication rates through real-time anatomy visualisation, sustaining premium camera integration investment.
    NIR fluorescence laparoscopy sustaining premium system investment at surgical programmes targeting colorectal, hepatobiliary, and urological complication rate reduction.
  4. Therapeutic endoscopy procedure volumes growing above diagnostic baseline, sustaining higher per-case consumable revenue from complex ESD, EMR, and haemostasis procedures.
    Therapeutic endoscopy growth sustaining above-diagnostic consumable revenue per case from higher device utilisation in complex ESD, EMR, and ERCP procedure categories.
  5. Robotic flexible endoscopy expanding in complex ERCP and POEM applications requiring bimanual instrument control above conventional endoscope technique.
    Robotic GI endoscopy sustaining premium system investment at advanced therapeutic endoscopy centres performing ERCP, POEM, and ESD procedures.
  6. Endoscopic bariatric procedures including intragastric balloon and sleeve gastroplasty sustaining high per-procedure device revenue above standard GI diagnostic endoscopy.
    Endoscopic bariatric procedure growth sustaining above-diagnostic-endoscopy device revenue from specialised bariatric endoscopy systems per treated patient.

Regional Outlook: Endoscopy Devices Market

  • North America: The largest endoscopy devices market, driven by high colonoscopy screening programme volumes at U.S. ambulatory endoscopy centres, rapid single-use bronchoscope and ureteroscope adoption at U.S. hospital systems following MDRO outbreak regulatory scrutiny, strong laparoscopic fluorescence imaging adoption at colorectal and hepatobiliary surgical programmes, and growing endoscopic bariatric procedure volumes at metabolic surgery centres.
  • Europe: Germany, France, the UK, and Italy anchor European endoscopy device demand. European gastroenterology practices are early adopters of endoscopic submucosal dissection for early gastric and colorectal cancer treatment, sustaining therapeutic endoscopy device utilisation per procedure above diagnostic baseline. EU reprocessing validation requirements have accelerated single-use endoscope evaluation at European hospital endoscopy departments.
  • Asia-Pacific: The fastest-growing endoscopy market, driven by Japan’s high per-capita gastroscopy and colonoscopy volumes and leadership in ESD technique development, China’s expanding endoscopy capacity at provincial hospital networks, South Korea’s organised colorectal cancer screening programme, and India’s growing gastroenterology procedure volumes at private hospital endoscopy centres. Japanese endoscope manufacturers Olympus and Fujifilm sustain dominant global market shares.

Competitive Landscape: Endoscopy Devices Market

Key Players: Olympus Corporation, Fujifilm Medical, Pentax Medical (Hoya Group), Medtronic (Endoscopy), Boston Scientific (Endoscopy), CONMED Corporation, Ethicon (J&J MedTech), Stryker (Endoscopy), Karl Storz, Richard Wolf, Storz Medical, Ambu (Single-Use Endoscopes), Innovizio Medical, Amscope Technologies, Endorobotics, Covidien (Medtronic), Becton Dickinson (Endoscopy Accessories), Cook Medical (Endoscopy Accessories)

  • Ambu A/S reported continued acceleration in aScope single-use bronchoscope and aScope Duodeno single-use duodenoscope adoption at U.S. and European hospital systems, with Ambu noting that single-use endoscope procedure volumes at existing customers increased year-over-year as hospital infection control committees converted additional endoscopy procedure categories from reusable to single-use workflows, and that new hospital account wins are coming increasingly from competitive conversion away from reusable flexible endoscope programmes.
  • Olympus Corporation confirmed commercial expansion of its EVIS X1 4K endoscopy platform with Texture and Colour Enhancement Imaging (TXI) AI visualisation technology across gastroenterology departments in Japan, Europe, and North America, with Olympus reporting that randomised controlled trial data comparing TXI-assisted colonoscopy to standard white-light colonoscopy demonstrated a statistically significant improvement in flat adenoma detection rate, supporting EVIS X1 capital replacement investment at colonoscopy screening programmes targeting measurable adenoma detection quality metrics.
  • Boston Scientific reported strong procedural adoption of its SpyGlass DS II direct visualisation system for cholangioscopy-guided biliary stone fragmentation and biliary stricture characterisation during ERCP, with Boston Scientific noting that SpyGlass single-use cholangioscope procedure volumes at U.S. and European ERCP centres continue to grow as interventional endoscopists convert biliary cases from conventional fluoroscopic ERCP guidance to direct cholangioscopic visualisation for improved diagnostic and therapeutic precision.

Consultant POV

The Endoscopy Devices market path to USD 90.71 billion by 2035 at 4.3% CAGR is anchored in single-use endoscope infection control adoption, 4K visualisation quality-driven detection improvement, therapeutic endoscopy procedure growth sustaining premium consumable revenue, and fluorescence laparoscopy complication reduction. Ambu single-use endoscope adoption acceleration, Olympus EVIS X1 4K AI visualisation expansion, and Boston Scientific SpyGlass cholangioscopy growth confirm that the endoscopy devices market will sustain steady above-general-medical-device-sector growth through 2035.

About Constancy Researchers Private Limited

Constancy Researchers is a global market intelligence and strategic advisory firm helping organizations navigate complex markets and make high-impact decisions with confidence. In an environment defined by rapid technological change, shifting demand patterns, and evolving competitive dynamics, we provide clarity where it matters most—at the point of decision-making. By combining deep industry understanding, rigorous analytics, and structured thinking, we enable leadership teams to identify opportunities, mitigate risks, and build strategies that drive sustainable growth.

Speak with an Analyst

    Download TOC